company background image
RAC logo

Race Oncology ASX:RAC Stock Report

Last Price

AU$1.84

Market Cap

AU$313.3m

7D

2.8%

1Y

52.1%

Updated

23 Jun, 2024

Data

Company Financials +

Race Oncology Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Race Oncology
Historical stock prices
Current Share PriceAU$1.84
52 Week HighAU$2.09
52 Week LowAU$0.64
Beta1.57
11 Month Change26.90%
3 Month Change34.80%
1 Year Change52.07%
33 Year Change-50.14%
5 Year Change3,371.70%
Change since IPO594.34%

Recent News & Updates

We Think Race Oncology (ASX:RAC) Needs To Drive Business Growth Carefully

May 10
We Think Race Oncology (ASX:RAC) Needs To Drive Business Growth Carefully

We're Not Very Worried About Race Oncology's (ASX:RAC) Cash Burn Rate

Jan 23
We're Not Very Worried About Race Oncology's (ASX:RAC) Cash Burn Rate

Recent updates

We Think Race Oncology (ASX:RAC) Needs To Drive Business Growth Carefully

May 10
We Think Race Oncology (ASX:RAC) Needs To Drive Business Growth Carefully

We're Not Very Worried About Race Oncology's (ASX:RAC) Cash Burn Rate

Jan 23
We're Not Very Worried About Race Oncology's (ASX:RAC) Cash Burn Rate

Here's Why We're Not Too Worried About Race Oncology's (ASX:RAC) Cash Burn Situation

Oct 05
Here's Why We're Not Too Worried About Race Oncology's (ASX:RAC) Cash Burn Situation

Companies Like Race Oncology (ASX:RAC) Are In A Position To Invest In Growth

Jun 20
Companies Like Race Oncology (ASX:RAC) Are In A Position To Invest In Growth

We're Interested To See How Race Oncology (ASX:RAC) Uses Its Cash Hoard To Grow

Feb 17
We're Interested To See How Race Oncology (ASX:RAC) Uses Its Cash Hoard To Grow

Here's Why We're Not At All Concerned With Race Oncology's (ASX:RAC) Cash Burn Situation

Oct 14
Here's Why We're Not At All Concerned With Race Oncology's (ASX:RAC) Cash Burn Situation

Here's Why We're Not Too Worried About Race Oncology's (ASX:RAC) Cash Burn Situation

Apr 01
Here's Why We're Not Too Worried About Race Oncology's (ASX:RAC) Cash Burn Situation

We're Hopeful That Race Oncology (ASX:RAC) Will Use Its Cash Wisely

Apr 05
We're Hopeful That Race Oncology (ASX:RAC) Will Use Its Cash Wisely

What Percentage Of Race Oncology Limited (ASX:RAC) Shares Do Insiders Own?

Mar 01
What Percentage Of Race Oncology Limited (ASX:RAC) Shares Do Insiders Own?

How Much Are Race Oncology Limited (ASX:RAC) Insiders Taking Off The Table?

Jan 07
How Much Are Race Oncology Limited (ASX:RAC) Insiders Taking Off The Table?

Shareholder Returns

RACAU BiotechsAU Market
7D2.8%1.7%0.8%
1Y52.1%5.3%10.3%

Return vs Industry: RAC exceeded the Australian Biotechs industry which returned 5.3% over the past year.

Return vs Market: RAC exceeded the Australian Market which returned 10.3% over the past year.

Price Volatility

Is RAC's price volatile compared to industry and market?
RAC volatility
RAC Average Weekly Movement9.9%
Biotechs Industry Average Movement10.8%
Market Average Movement8.3%
10% most volatile stocks in AU Market16.1%
10% least volatile stocks in AU Market3.2%

Stable Share Price: RAC's share price has been volatile over the past 3 months.

Volatility Over Time: RAC's weekly volatility (10%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2011n/aDaniel Tillettwww.raceoncology.com

Race Oncology Limited, a clinical stage global biotechnology company, focuses on cancer care. Its lead product, bisantrene, is a small molecule anthracene chemotherapeutic. The company is developing bisantrene to address the unmet need of patients across multiple oncology indications, exploring anti-cancer plus cardio-protection.

Race Oncology Limited Fundamentals Summary

How do Race Oncology's earnings and revenue compare to its market cap?
RAC fundamental statistics
Market capAU$313.32m
Earnings (TTM)-AU$11.17m
Revenue (TTM)AU$5.82m

53.9x

P/S Ratio

-28.0x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
RAC income statement (TTM)
RevenueAU$5.82m
Cost of RevenueAU$2.87m
Gross ProfitAU$2.95m
Other ExpensesAU$14.13m
Earnings-AU$11.17m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-0.066
Gross Margin50.73%
Net Profit Margin-192.14%
Debt/Equity Ratio0%

How did RAC perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.